The Cooper Companies Inc (STU:CP60)
€ 96.25 2 (2.12%) Market Cap: 19.14 Bil Enterprise Value: 21.48 Bil PE Ratio: 57.80 PB Ratio: 2.61 GF Score: 91/100

Cooper Companies Inc at JPMorgan Healthcare Conference Transcript

Jan 15, 2020 / 12:30AM GMT
Release Date Price: €76 (+2.01%)
K. Gong
JP Morgan Chase & Co, Research Division - Analyst

Let's get started. My name is Allen Gong. I'm with the medical supplies and devices team here at JPMorgan. It's my pleasure today to introduce Al White, the President and CEO of Cooper Companies. After the prepared remarks, we'll be hosting a breakout session in the Yorkshire room across the hall.

Albert G. White
The Cooper Companies, Inc. - President, CEO & Director

Thank you. Jump right into the presentation here. Obviously, our forward-looking statements. Cooper Companies, most of you probably know us. I recognize many of you in the audience. For those who do not, we're a medical device company, obviously, here at the JPMorgan Healthcare Conference. Been in the S&P 500 since 2016, and we're a leader in the vision care, contact lens industry and then also in the women's health. We did a little bit over $2.6 billion in revenue last year. And we're a global company operating in over 100 countries around the world. We have a workforce exceeding 12,000 employees.

So if we jump

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot